Sun Pharma Announces the Availability of UNLOXCYT™ (cosibelimab-ipdl) for Advanced Cutaneous Squamous Cell Carcinoma (aCSCC)

Author: Sun Pharmaceuticals Industries, Inc.

Posted Date: